SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.
Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, Molina J, Varona Santos J, Ge M, Sloan A, Kim JJ, Pedigo C, Bryn J, Volosenco I, Faul C, Zeidan YH, Garcia Hernandez C, Mendez AJ, Leibiger I, Burke GW, Futerman AH, Barisoni L, Ishimoto Y, Inagi R, Merscher S, Fornoni A.
Mitrofanova A, et al.
Nat Commun. 2019 Jun 19;10(1):2692. doi: 10.1038/s41467-019-10584-4.
Nat Commun. 2019.
PMID: 31217420
Free PMC article.
Here we report that SMPDL3b excess, as observed in podocytes in diabetic kidney disease (DKD), impairs insulin receptor isoform B-dependent pro-survival insulin signaling by interfering with insulin receptor isoforms binding to caveolin-1 in the PM. SM …
Here we report that SMPDL3b excess, as observed in podocytes in diabetic kidney disease (DKD), impairs insulin r …